Retour

Acadia Healthcare Company, Inc.

Qualité des données : 100%

ACHC

NASDAQ Healthcare Medical - Care Facilities

24,31 €

▲ 1,62 € (7,14%)

Cap. Boursière : 2,24B

Fourchette du Jour

22,59 € 24,32 €

Fourchette 52 Semaines

11,43 € 31,04 €

Volume

2 909 271

Moyenne 50J / 200J

17,68 € / 19,87 €

Clôture Précédente

22,69 €

Quick Summary

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (631 pairs)

Métrique	Action	Médiane du Secteur
P/E	-2,0	0,2
P/B	1,2	3,0
ROE %	-43,9	3,6
Net Margin %	-33,3	3,8
Rev Growth 5Y %	9,4	10,0
D/E	1,4	0,2

Objectif de Cours des Analystes

Hold

19,82 € -18.5%

Low: 14,00 € High: 25,00 €

P/E Prévisionnel

15,00

BPA Prévisionnel

1,51 €

Croissance BPA (est.)

+0,0%

CA Est.

3,41B

Estimations de Bénéfices

Période	BPA Est.	CA Est.	Analystes
FY2029	1,83 € 1,80 € – 1,87 €	4,20B	1
FY2028	1,88 € 1,84 € – 1,92 €	3,82B	2
FY2027	1,72 € 1,61 € – 1,96 €	3,61B	7

Earnings Surprises

Last 8 quarters

Quarter	Est. EPS	Actual EPS	Surprise
2026-02-25	0,01 €	0,07 €	+683,0%
2025-11-05	0,68 €	0,72 €	+5,9%
2025-08-05	0,71 €	0,83 €	+16,9%
2025-05-12	0,35 €	0,40 €	+14,3%
2025-02-27	0,75 €	0,64 €	-14,7%
2024-10-30	0,90 €	0,91 €	+1,1%
2024-07-31	0,87 €	0,91 €	+4,6%
2024-05-01	0,81 €	0,84 €	+3,7%

Dividend History

Yield

0,00%

Payout Ratio

0,00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

Points Clés

Revenue grew 9,38% annually over 5 years — modest growth

Earnings declined -531,42% over the past year

Negative free cash flow of -439,91M

PEG of 0,00 suggests growth is underpriced

Revenue growth is decelerating — 1Y growth trails 5Y average by 4,34%

Croissance

Revenue Growth (5Y)

9,38%

Revenue (1Y)5,04%

Earnings (1Y)-531,42%

FCF Growth (3Y)N/A

Qualité

Return on Equity

-43,91%

ROIC6,32%

Net Margin-33,29%

Op. Margin11,71%

Sécurité

Debt / Equity

1,36

Current Ratio1,55

Interest Coverage2,79

Valorisation

P/E Ratio

-2,03

Forward P/E15,00

P/B Ratio1,15

EV/EBITDA12,28

Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y)	5,04%	Revenue Growth (3Y)	6,35%
Earnings Growth (1Y)	-531,42%	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	9,38%	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	3,31B	Net Income (TTM)	-1,10B
ROE	-43,91%	ROA	-19,95%
Gross Margin	17,61%	Operating Margin	11,71%
Net Margin	-33,29%	Free Cash Flow (TTM)	-439,91M
ROIC	6,32%	FCF Growth (3Y)	N/A
Safety
Debt / Equity	1,36	Current Ratio	1,55
Interest Coverage	2,79
Dividends
Dividend Yield	0,00%	Payout Ratio	0,00%
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	-2,03	Forward P/E	15,00
P/B Ratio	1,15	P/S Ratio	0,68
PEG Ratio	0,00	Forward PEG	N/A
EV/EBITDA	12,28	Fwd EV/EBITDA	15,57
Forward P/S	0,66	Fwd Earnings Yield	6,67%
FCF Yield	-19,62%
Market Cap	2,24B	Enterprise Value	4,76B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	3,31B	3,15B	2,93B	2,61B	2,31B
Net Income	-1,10B	255,61M	-21,67M	273,14M	190,64M
EPS (Diluted)	-12,16	2,78	-0,24	2,98	2,10
Gross Profit	583,44M	711,98M	682,61M	2,51B	2,22B
Operating Income	387,97M	522,28M	506,60M	467,70M	414,47M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	5,53B	5,96B	5,36B	4,99B	4,77B
Total Liabilities	3,39B	2,77B	2,47B	2,09B	2,19B
Shareholders' Equity	1,95B	3,07B	2,78B	2,81B	2,52B
Total Debt	2,65B	2,09B	1,51B	1,53B	1,64B
Cash & Equivalents	133,24M	76,31M	100,07M	97,65M	133,81M
Current Assets	814,14M	577,49M	596,00M	506,13M	495,03M
Current Liabilities	525,19M	577,92M	885,78M	388,33M	404,86M